Literature DB >> 15309722

Proteomics to display tissue repair opposing injury response to LPS-induced liver injury.

Xiao-Wei Liu1, Fang-Gen Lu, Guang-Sen Zhang, Xiao-Ping Wu, Yu You, Chun-Hui Ouyang, Dong-Ye Yang.   

Abstract

AIM: To examine the protein expression alterations in liver injury/repair network regulation as a response to gut-derived lipopolysaccharide (LPS) treatment, in order to anticipate the possible signal molecules or biomarkers in signaling LPS-related liver injury.
METHODS: Male BALB/c mice were treated with intra-peritoneal (i.p.) LPS (4 mg/kg) and sacrificed at 0, 6, 24 and 30 h to obtain livers. The livers were stained with hematoxylin and eosin for histopathologic analyses. Total liver protein was separated by two-dimensional gel electrophoresis (2-DE). The peptide mass of liver injury or repair related proteins were drawn up and the protein database was searched to identify the proteins.
RESULTS: Observations were as follows: (1) TRAIL-R2 was down regulated in livers of LPS-treated mice. TNFAIP1 was significantly up regulated at 6 h, then down- regulated at 24, 30 h with silent expression during senescent stage. (2) The amount of metaxin 2 and mitochondria import inner membrane translocase subunit TIM8a (TIMM8A) was increased upon treatment with LPS. (3) P34 cdc2 kinase was significantly up-regulated 30 h after LPS administration with silent expression during senescent, 6, 24 h treated stage. (4) The amount of proteasome activator 28 alpha subunit (PA28), magnesium dependent protein phosphatase (MDPP) and lysophospholipase 2 was decreased 6 h after LPS treatment but recovered or up-regulated 24 and 30 h after LPS treatment.
CONCLUSION: LPS-treated mouse liver displaying a time-dependent liver injury can result in expression change of some liver injury or repair related proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309722      PMCID: PMC4572196          DOI: 10.3748/wjg.v10.i18.2701

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand.

Authors:  M D Josephs; F R Bahjat; K Fukuzuka; R Ksontini; C C Solorzano; C K Edwards; C L Tannahill; S L MacKay; E M Copeland; L L Moldawer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-05       Impact factor: 3.619

2.  Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide.

Authors:  M Pérez-Ruiz; J Ros; M Morales-Ruiz; M Navasa; J Colmenero; L Ruiz-del-Arbol; P Cejudo; J Clária; F Rivera; V Arroyo; J Rodés; W Jiménez
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

3.  Exacerbation of alcoholic liver injury by enteral endotoxin in rats.

Authors:  P Mathurin; Q G Deng; A Keshavarzian; S Choudhary; E W Holmes; H Tsukamoto
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

Review 4.  Intestinal endotoxemia as a pathogenetic mechanism in liver failure.

Authors:  De-Wu Han
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Two-dimensional database of mouse liver proteins: changes in hepatic protein levels following treatment with acetaminophen or its nontoxic regioisomer 3-acetamidophenol.

Authors:  M Fountoulakis; P Berndt; U A Boelsterli; F Crameri; M Winter; S Albertini; L Suter
Journal:  Electrophoresis       Date:  2000-06       Impact factor: 3.535

6.  The C66W mutation in the deafness dystonia peptide 1 (DDP1) affects the formation of functional DDP1.TIM13 complexes in the mitochondrial intermembrane space.

Authors:  Sabine Hofmann; Uli Rothbauer; Nicole Mühlenbein; Walter Neupert; Klaus-Dieter Gerbitz; Michael Brunner; Matthias F Bauer
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

7.  Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor alpha.

Authors:  C C Barton; E X Barton; P E Ganey; S L Kunkel; R A Roth
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

Review 8.  TRAIL/Apo-2L: mechanisms and clinical applications in cancer.

Authors:  R K Srivastava
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

9.  [TLR4 mRNA expression and liver injury in LPS-induced mouse].

Authors:  Xiao-wei Liu; Yu You; Fang-gen Lu
Journal:  Hunan Yi Ke Da Xue Xue Bao       Date:  2003-06

10.  Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta.

Authors:  E Seki; H Tsutsui; H Nakano; N Tsuji; K Hoshino; O Adachi; K Adachi; S Futatsugi; K Kuida; O Takeuchi; H Okamura; J Fujimoto; S Akira; K Nakanishi
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

View more
  7 in total

1.  Effect of liver regeneration after partial hepatectomy and ischemia-reperfusion on expression of growth factor receptors.

Authors:  P Baier; G Wolf-Vorbeck; S Hempel; U T Hopt; E von Dobschuetz
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

2.  Down-regulation of Stathmin Is Required for the Phenotypic Changes and Classical Activation of Macrophages.

Authors:  Kewei Xu; Rene E Harrison
Journal:  J Biol Chem       Date:  2015-06-16       Impact factor: 5.157

3.  Functional characterization of the promoter region of human TNFAIP1 gene.

Authors:  Mingjun Liu; Zhenhua Sun; Aidong Zhou; Hong Li; Liping Yang; Chang Zhou; Rushi Liu; Xiang Hu; Jianlin Zhou; Shuanglin Xiang; Jian Zhang
Journal:  Mol Biol Rep       Date:  2009-07-11       Impact factor: 2.316

Review 4.  The emerging role of the KCTD proteins in cancer.

Authors:  Annapaola Angrisani; Annamaria Di Fiore; Enrico De Smaele; Marta Moretti
Journal:  Cell Commun Signal       Date:  2021-05-17       Impact factor: 5.712

5.  A proteomic analysis of liver after ethanol binge in chronically ethanol treated rats.

Authors:  Annayya R Aroor; Lowery J Roy; Ricardo J Restrepo; Brian P Mooney; Shivendra D Shukla
Journal:  Proteome Sci       Date:  2012-04-30       Impact factor: 2.480

6.  TNFAIP1 interacts with KCTD10 to promote the degradation of KCTD10 proteins and inhibit the transcriptional activities of NF-κB and AP-1.

Authors:  Xiang Hu; Feng Yan; Fangmei Wang; Zijian Yang; Ling Xiao; Li Li; Shuanglin Xiang; Jianlin Zhou; Xiaofeng Ding; Jian Zhang
Journal:  Mol Biol Rep       Date:  2012-07-19       Impact factor: 2.742

7.  Alterations in the human lung proteome with lipopolysaccharide.

Authors:  Russell P Bowler; Nichole Reisdorph; Richard Reisdorph; Edward Abraham
Journal:  BMC Pulm Med       Date:  2009-05-11       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.